CARLEY ELSWICK: Open Payments
NPI 1073862363 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 68 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,188 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $285 |
| ABBVIE INC. | 18 | $249 |
| Alkermes, Inc. | 5 | $198 |
| Neurocrine BioSciences, Inc. | 8 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Lundbeck LLC | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Indivior Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
Products named: VRAYLAR, HETLIOZ, ARISTADA, INGREZZA, CAPLYTA, FANAPT, REXULTI, Auvelity.
Industry payments across WV — which companies pay providers there.
